2017 Drug Design and Delivery Symposium

This year of the symposium was organized to highlight the work being done by chemists to combat some of the diseases that plague us. Select any of the sessions below to hear experts detail the work that is being done in oncology, anti-infectives and immunology. 

I - Fighting Cancer
January 26 Fighting Cancer: Targeting CNS Malignancy with Kinase Inhibitors
Timothy P. Heffron - Genentech
Mark Wittman - Bristol-Myers Squibb
February 23 Fighting Cancer: Epigenetic targets for Oncology
Stuart Conway - Oxford
Sharan  Bagal - AstraZeneca
March 23 Fighting Cancer: Allostery and Targeting Cancer Cell Metabolism
Stefan Gross  - Agios
Scott Edmundson - AstraZeneca
Special Broadcast
April 20 Cystic Fibrosis: Discovery of CFTR Modulators
Peter Grootenhuis - Vertex
Nick Meanwell - Bristol-Myers Squibb
II - Anti-infectives
May 25 Anti-Infectives: Rational Approaches to the Design and Optimization
Jason Sello - Brown University 
Courtney Aldrich - University of Minnesota
June 29

Tuberculosis: An Introduction for Medicinal Chemists
Carl Nathan - Weill Cornell Medicine
Christopher Boyce - Merck

July 27 Viral Hepatitis: The Search for a Cure
Mike Sofia - Arbutus Biopharma
Stephen Mason - CaroGen Corporation
Special Broadcast
September 28 Spinal Muscular Atrophy
Kevin Hodgetts - Harvard Medical School
Alyson Weidmann - ACS Publications  
III - Immunology
October 26 Psoriasis: Treatment and Novel Approaches
Frank Narjes - AstraZeneca
John Morrison - Bristol-Myers Squibb
November 30 Treating Lupus: SLE Pathogenesis and Targeted Therapies
Laurence Menard - Bristol-Myers Squibb
Mary Struthers - Bristol-Myers Squibb

Content Advisors

Dan Erlanson
Carmot Therapeutics

Mark Wittman
Bristol-Myers Squibb 

ACS Webinars

Meet the Organizers

Annette Bak


Nicholas Meanwell
Bristol-Myers Squibb

John Morrison
Bristol-Myers Squibb


Janice Silverman
American Chemical Society


Co-Produced By